← Eichor
Study identifier: NCT06002932 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comparison of PROVISIONal 1-stent Strategy with DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.

Condition: Coronary Artery Disease · Ischemic Heart Disease  ·  Sponsor: Saint Vincent's Hospital, Korea

PhaseNA
Planned participants750
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

\[The Purpose of the Clinical Study\] The purpose of this randomized comparison study is to compare the 1-stent strategy with a drug-eluting balloon and the 2-stent strategy in patients with non-LM coronary true-bifurcation lesions. \[Hypothesis\] In this study, the researchers intend to verify the hypothesis that the 1-stent strategy with a drug-eluting balloon is non-inferior to the 2-stent strategy in terms of target lesion failures (cardiac death, target vessel MI, or target vessel revascularization).

This description comes directly from the study's public registry record.

Talk to the study team

Sung-Ho Her, MD. PhD.  ·  +82312598397  ·  hhhsungho@naver.com

Kyusup Lee, MD. PhD.  ·  +821090590389  ·  ajobi7121@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

St. Vincent's Hospital , the Catholic UniversitySuwon, Gyeonggi-do, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06002932